Evidence map›Paper›PMID 39311911›Full record

ArticleBasic research in cardiology2024

Single-cell transcriptomics reveal distinctive patterns of fibroblast activation in heart failure with preserved ejection fraction.

Jan D Lanzer, Laura M Wienecke, Ricardo O Ramirez Flores, Maura M Zylla, Celina Kley, Niklas Hartmann, Florian Sicklinger, Jobst-Hendrik Schultz, Norbert Frey, Julio Saez-Rodriguez and 1 more

Abstract read
In one paragraph

Article in Basic research in cardiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Serum amyloid A in HFpEF and cardiometabolic diseases.Basic research in cardiology · 2026
    Review
  14. Article
  15. Review
  16. Cardio-Vascular Extracellular Matrix: The Unmet Enigma.International journal of molecular sciences · 2026
    Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jan D Lanzer *Institute for Computational Biomedicine, Heidelberg University, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany.ORCID 0000-0001-9373-2160
Laura M Wienecke *German Center for Cardiovascular Research (DZHK), Partner Site Heidelberg, Heidelberg, Germany.ORCID 0000-0001-7587-8422
Ricardo O Ramirez FloresInstitute for Computational Biomedicine, Heidelberg University, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany.ORCID 0000-0003-0087-371X
Maura M ZyllaDepartment of Cardiology, Internal Medicine III, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
Celina KleyGerman Center for Cardiovascular Research (DZHK), Partner Site Heidelberg, Heidelberg, Germany.
Niklas HartmannGerman Center for Cardiovascular Research (DZHK), Partner Site Heidelberg, Heidelberg, Germany.ORCID 0009-0009-1799-7162
Florian SicklingerGerman Center for Cardiovascular Research (DZHK), Partner Site Heidelberg, Heidelberg, Germany.
Jobst-Hendrik SchultzInternal Medicine II, Heidelberg University Hospital, Heidelberg, Germany.
Norbert FreyGerman Center for Cardiovascular Research (DZHK), Partner Site Heidelberg, Heidelberg, Germany.
Julio Saez-Rodriguez *Institute for Computational Biomedicine, Heidelberg University, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany. pub.saez@uni-heidelberg.de.ORCID 0000-0002-8552-8976
Florian Leuschner *German Center for Cardiovascular Research (DZHK), Partner Site Heidelberg, Heidelberg, Germany. florian.leuschner@med.uni-heidelberg.de.ORCID 0000-0003-1157-474X

Funding

Deutsche Forschungsgemeinschaft CRC 1550Deutsche Forschungsgemeinschaft Heisenberg ProgrammDeutsche Gesellschaft für Kardiologie-Herz und Kreislaufforschung. DGK15/2020Deutsches Zentrum für Herz-Kreislaufforschung Heidelberg/ MannheimFondation Leducq Immuno-Fib HF (20CVD02)Klaus Tschira Stiftung Informatics for Life
6 · The paper itself

Abstract

Inflammation, fibrosis and metabolic stress critically promote heart failure with preserved ejection fraction (HFpEF). Exposure to high-fat diet and nitric oxide synthase inhibitor N[w]-nitro-l-arginine methyl ester (L-NAME) recapitulate features of HFpEF in mice. To identify disease-specific traits during adverse remodeling, we profiled interstitial cells in early murine HFpEF using single-cell RNAseq (scRNAseq). Diastolic dysfunction and perivascular fibrosis were accompanied by an activation of cardiac fibroblast and macrophage subsets. Integration of fibroblasts from HFpEF with two murine models for heart failure with reduced ejection fraction (HFrEF) identified a catalog of conserved fibroblast phenotypes across mouse models. Moreover, HFpEF-specific characteristics included induced metabolic, hypoxic and inflammatory transcription factors and pathways, including enhanced expression of Angiopoietin-like 4 (Angptl4) next to basement membrane compounds, such as collagen IV (Col4a1). Fibroblast activation was further dissected into transcriptional and compositional shifts and thereby highly responsive cell states for each HF model were identified. In contrast to HFrEF, where myofibroblast and matrifibrocyte activation were crucial features, we found that these cell states played a subsidiary role in early HFpEF. These disease-specific fibroblast signatures were corroborated in human myocardial bulk transcriptomes. Furthermore, we identified a potential cross-talk between macrophages and fibroblasts via SPP1 and TNFɑ with estimated fibroblast target genes including Col4a1 and Angptl4. Treatment with recombinant ANGPTL4 ameliorated the murine HFpEF phenotype and diastolic dysfunction by reducing collagen IV deposition from fibroblasts in vivo and in vitro. In line, ANGPTL4, was elevated in plasma samples of HFpEF patients and particularly high levels associated with a preserved global-longitudinal strain. Taken together, our study provides a comprehensive characterization of molecular fibroblast activation patterns in murine HFpEF, as well as the identification of Angiopoietin-like 4 as central mechanistic regulator with protective effects.

Indexed as

Disease Models, AnimalFibroblastsHeart FailureMice, Inbred C57BLSingle-Cell AnalysisStroke VolumeTranscriptomeAnimalsFemaleFibrosisGene Expression ProfilingHumansMaleMiceVentricular Function, LeftAngiopoietin-like 4Fibroblast activationHeart failure with preserved ejection fraction (HFpEF)Immune activationSingle-cell RNA sequencing

Identifiers

PMID39311911
PMCPMC11628589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.